Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0X0GI
|
|||
| Former ID |
DIB007976
|
|||
| Drug Name |
Gadoversetamide
|
|||
| Synonyms |
Optimark; MRI contrast agent, Mallinckrodt
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Myocardial infarction [ICD-11: BA41-BA43; ICD-9: 410] | Approved | [1], [2] | |
| Company |
Mallinckrodt Inc
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
C20H34GdN5O10
|
|||
| Canonical SMILES |
COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
|
|||
| InChI |
1S/C20H37N5O10.Gd/c1-34-9-3-21-16(26)11-24(14-19(30)31)7-5-23(13-18(28)29)6-8-25(15-20(32)33)12-17(27)22-4-10-35-2;/h3-15H2,1-2H3,(H,21,26)(H,22,27)(H,28,29)(H,30,31)(H,32,33);/q;+3/p-3
|
|||
| InChIKey |
HBEAOBRDTOXWRZ-UHFFFAOYSA-K
|
|||
| CAS Number |
CAS 131069-91-5
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:31644
|
|||
| ADReCS Drug ID | BADD_D00994 ; BADD_D01621 | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 2 | ClinicalTrials.gov (NCT01092754) Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Optimark (Gadoversetamide) in Pediatric Patients. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.